Andrew Yukawa is a Consultant in our San Francisco office. His willingness to both learn from his teammates and his generosity in sharing his own skills have made him a key member of

Having weathered many challenges in Q2 2020, biopharmaceutical firms, by and large, presented a case for optimism during Q3 2020 earnings calls. However, alongside this optimistic outlook were a number of voices expressing

Uma Sankar is a Software Development Lead in our Chennai office. She’s been at ZoomRx for over four years and has worked in software development for seven. Uma’s deep understanding of

Oncologists are growing accustomed to attending the field’s major meetings virtually, with AACR, ASCO, and now ESMO 2020 having gone fully digital.While the virtual format has undoubtedly impacted attendees’ experiences and

A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities

Oncologists often develop individualized treatment plans to ensure patients are receiving care tailored to their situation. Here are factors influencing their decisions.

Despite the disruption and transition to a completely virtual format, 2020 was not an off-year for ASCO. Nearly all oncologists who attended this year’s ASCO Annual Meeting felt that it represented at

Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on

With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and

Often, traditional research doesn't answer all questions pertaining to clinical treatment decisions. Here's ZoomRx's new approach to address such questions.

As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and

While opioid abuse deterrence and deprescribing topics were again center stage at the American Academy of Pain Medicine (AAPM) Annual Meeting this year—held February 26-March 1 in National Harbor, MD—headache and

The following is based on a presentation given by ZoomRx at the Pharma Market Research Conference in Newark, NJ on Feb 5-6, 2020. Please reach out via the form at the bottom of

The continued growth of personalized medicine and other treatment trends presents new challenges for market researchers. Within patient populations that were once considered relatively homogenous, new, smaller patient subgroups are being identified as